IRIS

1.1 Articolo in rivista: [15372] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 7.201 a 7.220 di 15.372
Titolo Data di pubblicazione Autore(i) File
The current role of telomerase in the diagnosis of bladder cancer 1-gen-2009 Bravaccini, S; Casadio, V; Amadori, D; Calistri, D; Silvestrini, R.
The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects 1-gen-2021 Bravaccini, S; Bronte, G; Petracci, E; Puccetti, M; D'Arcangelo, M; Ravaioli Tumedei, Mm; Maltoni, R; Delmonte, A; Cappuzzo, F; Crinò, L
The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial 1-gen-2020 Bravaccini, S; Bronte, G; Scarpi, E; Ravaioli, S; Maltoni, R; Mangia, A; Tumedei, Mm; Puccetti, M; Serra, P; Gianni, L; Amaducci, L; Biglia, N; Bounous, V; Paradiso, Av; Silvestrini, R; Amadori, D; Rocca, A
The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer 1-gen-2021 Bronte, G; Puccetti, M; Petracci, E; Landi, L; Cravero, P; Scodes, S; Ulivi, P; Ravaioli, S; Tumedei, Mm; Burgio, Ma; Cappuzzo, F; Delmonte, A; Crino, L; Bravaccini, S
The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot Study 1-gen-2011 Sacanna, E; Ibrahim, T; Gaudio, M; Mercatali, L; Scarpi, E; Zoli, W; Serra, P; Bravaccini, S; Ricci, R; Serra, L; Amadori, D
TMB in NSCLC: A Broken Dream? 1-gen-2021 Bravaccini, S; Bronte, G; Ulivi, P
Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients 1-gen-2014 Rambau, P; Masalu, N; Jackson, K; Chalya, P; Serra, P; Bravaccini, S
Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls 1-gen-2021 Bravaccini, S; Maltoni, R
Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiota 1-gen-2023 Pirini, F; Cortesi, M; Tumedei, Mm; Zanoni, M; Ravaioli, S; Bravaccini, S
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinomain situ 1-gen-2020 Farolfi, A; Petracci, E; Serra, L; Ravaioli, A; Bravaccini, S; Ravaioli, S; Tumedei, Mm; Ulivi, P; Canale, M; Puccetti, M; Falcini, F; Folli, S; Curcio, A; Rocca, A
Urinary biomarkers of nonmuscle-invasive bladder cancer: current status and future potential 1-gen-2012 Calistri, D; Casadio, V; Bravaccini, S; Zoli, W; Amadori, D
Urine telomerase activity for the detection of bladder cancer in females 1-gen-2007 Bravaccini, S; Sanchini, Ma; Granato, Am; Gunelli, R; Nanni, O; Amadori, D; Calistri, D; Silvestrini, R
Urine telomerase: An important marker in the diagnosis of bladder cancer 1-gen-2004 Sanchini, Ma; Bravaccini, S; Medri, L; Gunelli, R; Nanni, O; Monti, F; Baccarani, Pc; Ravaioli, A; Bercovich, E; Amadori, D; Calistri, D
Usefulness of immunological detection of the human telomerase reverse transcriptase 1-gen-2005 Volpi, A; Bravaccini, S; Medri, L; Cerasoli, S; Gaudio, M; Amadori, D
What impacts the cost-effectiveness of PD-L1 testing in non-small cell lung cancer? 1-gen-2019 Bravaccini, S
What Influences the Choice of Ibrutinib-Rituximab vs Classic Chemoimmunotherapy for Chronic Lymphocytic Leukemia? 1-gen-2020 Bravaccini, S; Martinelli, G; Cerchione, C
What is the best clinical pathological score to identify high-risk patients with lobular carcinoma of the breast who are likely to benefit from adjuvant chemotherapy? 1-gen-2019 Maltoni, R; Bravaccini, S
What to look for in cell-free DNA from breast cancer patients 1-gen-2018 Bronte, G; Ravaioli, S; Bravaccini, S
What's the best modality for patient selection for predicting response to PD-1/PD-L1 inhibitors? 1-gen-2020 Bravaccini, S; Ulivi, P
Megalencephaly: Classification, Genetic Causes, and Related Syndromes 1-gen-2023 Leonardi, R.; Licciardello, L.; Zanghi, A.; La Cognata, D.; Maniaci, A.; Vecchio, M.; Polizzi, A.; Falsaperla, R.; Pratico, A. D.
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 7.201 a 7.220 di 15.372
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista15368
  • 4 Contributo in Atti di Convegno ...2
  • 2 Contributo in Volume1
Autore
  • BARBANTI, MARCO455
  • PAPPALARDO, FEDERICO344
  • DOMINGUEZ RODRIGUEZ, LIGIA JULIANA331
  • GEBBIA, VITTORIO326
  • TUMINO, AURORA311
  • GULINO, MARISA283
  • ELIA, MAURIZIO281
  • UMANA, GIUSEPPE EMMANUELE277
  • MANIACI, ANTONINO265
  • MAGGI, PAOLO260
Data di pubblicazione
  • In corso di stampa17
  • 2020 - 20267039
  • 2010 - 20195807
  • 2000 - 20091967
  • 1990 - 1999480
  • 1980 - 198960
  • 1979 - 19791
Editore
  • Trans Tech Publications1
Rivista
  • INTERNATIONAL JOURNAL OF MOLECULA...225
  • JOURNAL OF CLINICAL MEDICINE153
  • CANCERS122
  • INTERNATIONAL JOURNAL OF ENVIRONM...110
  • LNS. ACTIVITY REPORT85
  • PHD KORE REVIEW78
  • DIAGNOSTICS77
  • RIVISTA DELLA COOPERAZIONE GIURID...76
  • SCIENTIFIC REPORTS73
  • SUSTAINABILITY72
Serie
  • ADVANCED MATERIALS RESEARCH1
  • WORKING PAPERS RES1
Keyword
  • COVID-19257
  • Humans250
  • Female133
  • Male127
  • SARS-CoV-2108
  • inflammation103
  • oxidative stress85
  • Italy78
  • Adult69
  • Middle Aged67
Lingua
  • eng10819
  • ita2587
  • fre66
  • spa64
  • lat12
  • ger11
  • por6
  • ara3
  • cat3
  • enm2
Accesso al fulltext
  • no fulltext15371